{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:33:23Z","timestamp":1791470003348,"version":"4.3.4"},"reference-count":61,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2017,8,3]]},"DOI":"10.1080\/13543784.2017.1353600","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T07:57:13Z","timestamp":1499414233000},"page":"985-989","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Lurasidone for the treatment of irritability and anger in autism spectrum disorders"],"prefix":"10.1080","volume":"26","author":[{"given":"Lynn","family":"McClellan","sequence":"first","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli C.","family":"Dominick","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest V.","family":"Pedapati","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan K.","family":"Wink","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Erickson","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-4993(18)30142-1"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S84585"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.08.032"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/00405848209542992"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.64719\/pb.4346","article-title":"Treatment of Autism spectrum disorder in children and adolescents","volume":"46","author":"DeFilippis M","year":"2016","unstructured":"DeFilippis M, Wagner K. Treatment of Autism spectrum disorder in children and adolescents. Psychopharmacy Bull. 2016;46:18\u201341.","journal-title":"Psychopharmacy Bull"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-0264-F"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3782"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(15)30944-5"},{"key":"e_1_3_2_13_1","unstructured":"Council NAMH From discovery to cure: accelerating the development of new and personalized interventions for mental illnesses. NIMH;2010"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201400044"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1058780"},{"key":"e_1_3_2_16_1","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri MC","year":"2014","unstructured":"Mauri MC, Paletta S, Maffini M, et al. Clinical pharmacology of atypical antipsychotics: an update. Excli J. 2014;13:1163\u20131191.","journal-title":"Excli J"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2010.04.001"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90066-5"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2016.04.002"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2338"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04905"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10060907"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.01.009"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.01.020"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070985"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13070984"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2838-2"},{"key":"e_1_3_2_28_1","first-page":"354","article-title":"Lurasidone treatment in a child with autism spectrum disorder with irritability and aggression","volume":"24","author":"Millard PH","year":"2014","unstructured":"Millard PH, McClaren JL, Coffey B. Lurasidone treatment in a child with autism spectrum disorder with irritability and aggression. Advan Pediatric Psychopharm. 2014;24:354\u2013356.","journal-title":"Advan Pediatric Psychopharm"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-015-2628-x"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"e_1_3_2_31_1","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman MG","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, et al. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic. 1985;89:485\u2013491.","journal-title":"Am J Ment Defic"},{"key":"e_1_3_2_32_1","volume-title":"Clinical global impression (CGI)","author":"Guy W","year":"1976","unstructured":"Guy W. Clinical global impression (CGI). Rockville: U.D.o.H. Editor; 1976."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000220854.79144.e7"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/106342669700500404"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_3_2_36_1","first-page":"3","article-title":"Abnormal involuntary movement scale (AIMS)","volume":"4","author":"National Institute of Mental Health, (NIMH)","year":"1975","unstructured":"National Institute of Mental Health, (NIMH). Abnormal involuntary movement scale (AIMS). Early Clin Drug Eval Unit Intercom. 1975;4:3\u20136.","journal-title":"Early Clin Drug Eval Unit Intercom"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.2462"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.55"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05933"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371506001005"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.07.055"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3068-y"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2010.487860"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0034"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0154"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3022-z"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-013-1963-z"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.07.011"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S35673"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-016-0088-6"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00250"},{"key":"e_1_3_2_53_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/aur.109","article-title":"A pharmacogenetic study of escitalopram in autism spectrum disorders","volume":"3","author":"Owley T","year":"2010","unstructured":"Owley T, Brune CW, Salt J, et al. A pharmacogenetic study of escitalopram in autism spectrum disorders. Autism Res. 2010;3:1\u20137.","journal-title":"Autism Res"},{"key":"e_1_3_2_54_1","first-page":"73","article-title":"Behavioral and pharmacogenetics of aggressive behavior","volume":"12","author":"Takahashi A.","year":"2012","unstructured":"Takahashi, A., et al. Behavioral and pharmacogenetics of aggressive behavior. Curr Behav Sci. 2012;12:73\u2013138.","journal-title":"Curr Behav Sci"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2014.16.4\/jpouget"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371405900203"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-014-0106-0"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000474"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2014.12.1.19"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12470"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0158"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S107772"},{"key":"e_1_3_2_63_1","volume-title":"Why is autism associated with aggressive and challenging behaviors?","author":"Autismspeaks Inc., A","year":"2012","unstructured":"Autismspeaks Inc., A. Why is autism associated with aggressive and challenging behaviors? 2012."}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2017.1353600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:10:51Z","timestamp":1770394251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2017.1353600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8,3]]}},"alternative-id":["10.1080\/13543784.2017.1353600"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2017.1353600","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}